CYP19A1 and polycystic ovary syndrome: Preliminary data from our laboratory indeed confirm that D-Chiro-Ins enhances the activity of key androgenic enzymes (such as 3-βHSD) while specifically inhibiting aromatase (Cyp19A1) synthesis and FSH receptor (FSHr) release in ovary cells obtained from PCOS animals.